Abstract
Vitamin A is essential for normal growth and development. Epidemiology and laboratory studies suggest that decreased vitamin A levels and defective metabolism/action may contribute to the genesis of certain cancers. Based on this information, natural and synthetic derivatives of vitamin A (retinoids) have been used for chemoprevention of cancer. Retinoids have had some success in the chemoprevention of leukoplakia and in the decreased incidence of second primaries in head and neck cancer. There is little information on biomarkers that can be used to assess the efficacy of the chemopreventive activity of retinoids. The ability of retinoids to induce RARb has been consistently shown to correlate with the response of cells and tissues to retinoic acid, but few other biomarkers have been certified as indicators of retinoid activity. In light of the failure of the ATBC and CARET clinical intervention trials for chemoprevention of lung cancer, greater use of animal models for chemoprevention studies is necessary. The potential combination of phytochemicals that inhibit DNA methyltransferase activity with retinoids holds promise for more effective chemoprevention of retinoid-unresponsive premalignant lesions.
Similar content being viewed by others
Article PDF
References
Hofmann C, Eichele G . Retinoids in development. In: Sporn M, Roberts AB, Goodman M, editors. The retinoids, biology, chemistry and medicine, 2nd ed. New York: Plenum Press; 1994. p387–441.
Eskild W, Hansson V . Vitamin A functions in the reproductive organs. In: R Blomhoff, editor. Vitamin A in health and disease. New York: Marcel Dekker; 1994. p 531–9.
DeLuca LM . Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J 1991; 5: 2924–33.
Wald G . The molecular basis of visual excitation. Nature 1968; 219: 800–07.
Thompson JN, Howell JM, Pitt GAJ . Vitamin A and reproduction in rats. Proc R Soc Lond B 1964; 159: 510–35.
Wolbach SB, Howe PR . Tissue changes following deprivation of fat-soluble A vitamin. Proc Soc Exp Biol Med 1925; 77: 825.
Lasnitzki I . The influence of hypervitaminosis on the effect of 20-methylcholanthrene on mouse prostate glands growth in vitro. Br J Cancer 1955; 9: 434–41.
Saffiotti U, Montessano R, Sellakumar AR, Borg SA . Experimental cancer of the lung: Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer 1967; 20: 857–64.
Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, Ping P, et al. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 2007; 315: 820–5.
Pasutto F . Stricht H, Hammersen G, Gillessen-Kaesbach G, Fitzpatrick DR, Nürnberg G, et al. Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, disphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet 2007; 80: 550–60.
Levin MS, Li E, Ong DE, Gordon JI . Comparison of the tissue-specific expression and developmental regulation of two closely linked rodent genes encoding cytosolic retinol-binding proteins. J Biol Chem 1987; 262: 7118–25.
Blaner WS, Das K, Mertz JR, Das SR, Goodman DS . Effects of dietary retinoic acid on cellular retinol- and retinoic acid-binding protein levels in various rat tissues. J Lipid Res 1986; 27: 1084–8.
Astrom A, Tavakkol A, Pattersson U, Cromie M, Elder JT, Voorhees JJ . Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). J Biol Chem 1991; 266: 17662–6.
Rajan N, Kidd GL, Tamage DA, Blaner WS, Suhara A, Godman DS . Cellular retinoic acid-binding protein messenger RNA levels in rat tissue and localization in rat testis. J Lipid Res 1991; 32: 1195–204.
Ross AC, Zolfaghari R, Weisz J . Vitamin A: recent advances in the biotransformation, transport, and metabolism of retinoids. Curr Opin Gastroenterol 2001; 17: 184–92.
Delva L, Bastie JN, Rochette-Egly C, Kraiba R, Balitrand N, Despouy G, et al. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 1999; 19: 7158–67.
Budh AS, Noy N . Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol Cell Biol 2002; 22: 2632–41.
Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992; 68: 397–406.
Levin AA, Sturgenbeker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, et al. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR?. Nature 1992; 355: 359–61.
Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM . Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224–9.
Predke PF, Zamble D, Sarkar B, Giguere V . Ordered binding of retinoic acid and retinoid-X receptors to asymmetric response elements involves determinants adjacent to the DNA-binding domain. Mol Endocrinol 1994; 8: 31–9.
Carlsberg C, Bend I, Ways A, Meier E, Sturzenbecker LJ, Grippo JF, et al. Two nuclear signaling pathways for vitamin D. Nature 1993; 361: 657–60.
Kliewer SA, Umensono K, Mangelsdorf DJ, Evans RM . Retinoid X receptors interact with nuclear receptors in retinoic acid, thyroid hormone, and vitamin D3 signaling. Nature 1992; 335: 446–9.
Leid M, Kastner P, Lyons R, Nakshari H, Saunders M, Zacharewski T, et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 1992; 68: 377–95.
Bugge TH, Pohl J, Lonnoy O, Stunnenberg HG . RXRγ, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J 1992; 11: 1409–10.
Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W . Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferators-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 1993; 90: 2160–4.
Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM . Convergence of 9-cis retinoic acid and peroxisome proliferators signaling pathways through heterodimer formation of their receptors. Nature 1992; 358: 771–4.
Kliewer SA, Umesono K, Heyman RH, Mangelsdorf DJ, Dyck JA, Evands RM . Retinoid X receptor–COUP-TF interactions modulate retinoic acid signaling. Proc Natl Acad Sci USA 1992; 89: 1448–52.
Perlmann T, Jansson L . A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 1995; 9: 769–82.
Zhang XK, Hoffmann B, Tran PBV, Graupner G, Pfahl M . Ret-inoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992; 355: 441–6.
Sucov HM, Murakami KK, Evans RM . Characterization of an autoregulated response element in the mouse retinoic acid receptor type β gene. Proc Natl Acad Sci USA 1990; 5392–6.
Umesono K, Murakami KK, Thompson CC, Evans RM . Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991; 65: 1255–66.
Mader S, Leroy O, Chen JY, Chambon P . Multiple parameters control the selectivity of nuclear receptors for their response elements: selectivity and promiscuity in the response element recognition by retinoic acid receptors and retinoid X receptors. J Biol Chem 1993; 268: 591–600.
Jho SH, Radoja N, Im MJ, Tomic-Canic M . Negative response elements in keratin genes mediate transcriptional repression and the cross-talk among nuclear receptors. J Biol Chem 2001; 276: 45914–20.
Davies RE . Effect of vitamin A on 7,12-dimethylbenz(a)an-thracene-induced papillomas in rhino mouse skin. Cancer Res 1967; 27: 237–41.
Harris CC, Sporn MB, Kaufman DG, Smith JM, Jackson FE, Saffiotti U . Histogenesis of squamous metaplasia in the hamster tracheal epithelium caused by vitamin A deficiency of benzo[a] pyrene Ferric oxide. J Natl Cancer Inst 1972; 48: 743–61.
Rogers AE, Herndon BJ, Newberne PM . Induction by dimethylhydrzine of intestinal carcinoma in normal rats and rats fed high or low levels of vitamin A. Cancer Res 1973; 33: 1003–9.
McCormick DL, Burns FJ, Albert RE . Inhibition of benz[a] pyrene-induced mammary carcinogenesis by retinyl acetate. J Natl Cancer Inst 1981; 66: 559–64.
Nauss KM, Bueche D, Newberne PM . Effect of vitamin A nutri-ture on experimental esophageal carcinogenesis. J Natl Cancer Inst 1987; 79: 145–7.
DeLuca LM, Tarone R, Huynh M, Jones CS, Chen LC . Dietary retinoic acid inhibits mouse skin carcinogenesis irrespective of age of initiation. Nutr Cancer 1996; 25: 249–57.
Hankin JH, Kolonel LN, Hinds MW . Dietary history methods for epidemiologic studies: application in a case-control study of vitamin A and lung cancer. J Natl Cancer Inst 1984; 73: 1417–22.
Mettlin CJ . Epidemiology of vitamin A and aerodigestive cancer. Adv Exp Med Biol 1992; 320: 21–6.
Moon RC . Vitamin A, retinoids and breast cancer. Adv Exp Med Biol 1994; 364: 101–07.
Guo Z, Nanus DM, Ruiz A, Rando RR, Bok D Gudas LJ . Reduced levels of retinyl esters and vitamin A in human renal cancers. Cancer Res 2001; 61: 2774–81.
Guo Z, Knudsen BS, Peehl DM, Ruiz A, Bok D, Rando RR, et al. Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens. Cancer Res 2002; 62: 1654–61.
Jeronimo C, Oliveria HR, Lobo F, Pais I, Teixeira MR, Lopes C . Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer. J Clin Pathol 2004; 57: 872–6.
Van Wauwe JP, Coene MC, Goossens J, Van Nijen G, Cools W, Lauwers W . Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid. J Pharmacol Exp Ther 1988; 245: 718–22.
Soprano DR, Qin P, Soprano KF . Retinoic acid receptors and cancers. Ann Rev Nutr 2004; 24: 201–21.
McGregor F, Wagner E, Felix D, Soutar D, Parkinson K, Harrison PR . Inappropriate retinoic acid receptor β expression in oral dyspla sia s: correlation with acqu isition of the immortal phenotype. Cancer Res 1977; 57: 3886–9.
Picard E, Seguin C, Momhoven N, Rochette-Egly C, Siat J, Borrelly J, et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst 1999; 91: 1059–66.
Qiu H, Zhang W, El-Naggar AK, Lippman SM, Lin P, Lotan R, et al. Loss of retinoic acid receptor β expression is an early event during esophageal carcinogenesis. Am J Pathol 1999; 155: 1519–23.
Swisshelm K, Ryan K, Lee X, Tsou HC, Peacocke M, Sager R . Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ 1994; 5: 133–41.
Zhang XK, Liu Y, Lee MO, Pfahl M . A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res 1994; 54: 5663–9.
Lin B, Chen G, Xiao D, Lollure SK, Cao X, Su H, et al. Orphan receptor COUP-TF is required for induction of retinoic acid receptor, growth inhibition and apoptosis by retinoic acid in cancer cells. Mol Cell Biol 2000; 20: 957–70.
Wu Q, Li Y, Liu R, Agadir A, Lee MO, Liu Y, et al. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nurr77 and COUP-TF and their heterodimerization. EMBO J 1997; 16: 1545–69.
Arapshian A, Kuppumbatti YS, Mira-y-Lopez R . Modulation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor β gene silencing in MCF7 breast cancer cells. Oncogene 2000; 19: 4066–70.
Cote S, Sinnett D, Momparler RL . Demethylation by 5-aza-2′ deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor β gene in human colon carcinoma cells. Anticancer Drugs 1998; 9: 743–50.
Nakayama T, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, Ito H, et al. The role of epigenetic modifications in retinoic acid receptor β2 gene expression in human prostate cancers. Lab Invest 2001; 81: 1049–57.
Cote S, Momparier RL . Activation of the retinoic acid receptor β gene by 5-aza-2′-deoxycytidine in human DLD-1 colon carcinoma cells. Anticancer Drugs 1995; 8: 56–61.
Sirchia SM, Ren M, Pili R, Siron E, Somenzi G, Ghidoni R, et al. Endogenous reactivation of the RAR?2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res 2002; 62: 2455–61.
Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315: 1501–5.
Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 1993; 328: 15–20.
Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Nair MK . Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 1988; 40: 93–101.
Han J, Jiao L, Sun Z, Gu QM, Scanlon KJ . Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent. In Vivo 1990; 4: 153–60.
Costa A, Formelli F, Chiesa F, Decensi A, de Paol G, Veronesi U . Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res 1994; 54: 2032s–7s.
Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, et al. Suppression of retinoic acid receptor β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995; 332: 1405–10.
Misset JL, Mathe G, Santelli G, Gouveia J, Homasson JP, Sudre MC, et al. Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatment. Cancer Detect Prev 1986; 9: 167–70.
Lippman SM, Kessler JF, Meyskens FL . Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 1987; 71: 391–405.
Kligman AM, Thorne EG . Topical therapy of actinic keratosis with tretinoin. In: Marks R, editor. Retinoids in cutaneous malignancy. Cambridge: Blackwell Scientific; 1991. p 66–73.
Moriarty M, Dunn J, Darragh A, Lambe R, Brick I . Etretinate in treatment of actinic keratosis: A double blind crossover study. Lancet 1982; 1: 364–5.
Watson AB . Preventive effect of etretinate therapy on multiple actinic keratoses. Cancer Detect Prev 1986; 9: 161–5.
Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL . Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318: 1633–7.
Kraemer K, Di Giovanna JJ, Peck GL . Oral isotreinoin prevention of skin cancer in xeroderma pigmentosum: Individual variation in dose response. J Invest Dermatiol 1990; 94: 544.
Kelly JW, Sabto J, Gurr FW . Retinoids to prevent skin cancer in organ transplant recipients. Lancet 1991; 338: 1407.
Moon TE, Levine N, Cartmel B, Bangert JL . Retinoids in prevention of skin cancer. Cancer Lett 1997; 114: 203–5.
Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. N Engl J Med 1990; 323: 789–95.
Tangrea JA, Edwards BK, Taylor PR, Hartman AM, Peck GL, Salasche SJ, et al. Long term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: A multicenter clinical trail. J Natl Cancer Inst 1992; 84: 328–32.
Graham V, Surwit ES, Weiner S, Meyskens FL . Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap. West J Med 1986; 145: 192–5.
Meyskens FL, Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 1994; 86: 539–43.
Lawrence JA, Merino MJ, Simpson JF, Manrow RE, Page DL, Steeg PS . A high risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor. Cancer Epid Biomarkers Prevent 1998; 7: 29–35.
Elmore FL, Jain A, Siddiqui S, Tohidian N, Meyskens FL, Steele VE, et al. Development and characteristics of a human cell assay for screening agents for melanoma prevention. Melanoma Res 2005; 17: 42–50.
Papadimitrakopoulou VA, Hong WK . Biomolecular markers as intermediate end points in chemoprevention trials of upper aerodigestive tract cancer. Int J Cancer 2000; 88: 852–5.
Lippman SM, Shin DM, Lee JJ, Batsakis JG, Lotan R, Tainsky MA, et al. p53 and retinoid chemoprevention of oral carcino-genesis. Cancer Res 1995; 55: 16–19.
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP . CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681–6.
Xu XC, Lee JS, Lee JJ, Morice RC, Liu X, Lippman SM, Nuclear retinoid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J Natl Cancer Inst 1999; 91: 1317–21.
Widschwendter M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendter A, Mayr A, et al. Loss of retinoic acid receptor expression in breast cancer and morphologically normal adjacent tissues but not in the normal breast tissue distant from the cancer. Cancer Res 1997; 57: 4158–61.
Picard E, Seguin C, Momhoven N, Rochette-Egly C, Siat J, Borrelly J, et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst 1999; 91: 1059–66.
Hoon DS, Spugnardi M, Kuo C, Huang SK, Morton DL, Taback B . Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 2004; 23: 4014–22.
Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K . Expression of retinoic acid β mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 1995; 6: 1077–88.
Xu XC, Liu X, Tahara E, Lippman SM, Lotan R . Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 1999; 59: 2477–83.
Hayashi K, Yokozaki H, Goodison S, Oue N, Suzuki T, Lotan R, et al. Inactivation of retinoic acid receptor β by promoter CpG hypermethylation in gastric cancer. Differentiation 2001; 69: 13–21.
Yang Q, Shan L, Yoshimura G, Nakamura M, Nakamura Y, Suzuma T, et al. 5-aza-2′-deoxycytidine induces retinoic acid receptor beta2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells. Anticancer Res 2002; 22: 2753–6.
Mongan N P, Gudas LJ . Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of RAR?2 in breast cancer cells. Mol Cancer Ther 2005; 4: 477–86.
Albanes D, Heinonen OP, Huttunen JK, Taylor PP, Virtamo J, Edwards BK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha Tocopherol Beta-carotene Cancer Prevention Study. Am J Clin Nutr 1995; 62: 1425S–30S.
Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1966; 88: 1550–9.
Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, Russell M . Retinoid signaling and activator protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999; 91: 60–6.
McCormick DL, Johnsen WD, Rao KV, Bowman-Gram T, Steele VE, Lubet RA, et al. Comparative activity of N-(4-hydroxy-phenyl)-all-trans-retinamide and α-difluoromethylornithine as inhibitors of lymphoma induction in PIM transgenic mice. Carcinogenesis 1996; 17: 2513–7.
Wu K, Kim HT, Rodiquez JL, Munoz-Medellin D, Mohsin SK, Hilsenbeck SG, et al. 9-cis Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice. Clin Cancer Res 2000; 6: 3696–704.
Wu K, Kim HT, Rodriquez JL, Hilsenbeck SG, Mohsin SK, Xu XC, et al. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069. Cancer Epidemiol Biomarkers Prev 2002; 11: 467–74.
McCormick DL, Rao KV . Chemoprevention of hormone-dependent prostate cancer in the Wistar–Unilever rat. Eur Urol 1999; 35: 464–7.
Becci PJ, Thompson HJ, Strum JM, Brown CC, Sporn MB, Moon RC . N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder cancer in C57BL/6 X DBA/2F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res 1981; 41: 927–32.
Curphey TJ, Kuhlmann ET, Roebuck BD, Longnecker DS . Inhibition of pancreatic and liver carcinogenesis in rats by retinoid- and selenium-supplemented diets. Pancreas 1988; 3: 36–40.
Ross DA, Kish P, Muraszko KM, Blaivas M, Srawderman M . Effect of dietary vitamin A or N-acetylcysteine on ethylnitrosurea-induced rat gliomas. J Neurooncol 1998; 40: 29–38.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niles, R. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention. Acta Pharmacol Sin 28, 1383–1391 (2007). https://doi.org/10.1111/j.1745-7254.2007.00685.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00685.x
Keywords
This article is cited by
-
Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer
BMC Cancer (2022)
-
NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling
Journal of Experimental & Clinical Cancer Research (2019)
-
A clinically relevant bi-cellular murine mammary tumor model as a useful tool for evaluating the effect of retinoic acid signaling on tumor progression
Breast Cancer (2013)
-
Apoptosis induced by synthetic retinoic acid CD437 on human melanoma A375 cells involves RIG-I pathway
Archives of Dermatological Research (2009)